Assenagon Asset Management S.A. Reduces Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Assenagon Asset Management S.A. lowered its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 96.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,067 shares of the company's stock after selling 417,647 shares during the period. Assenagon Asset Management S.A.'s holdings in Oscar Health were worth $198,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. JPMorgan Chase & Co. increased its position in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the period. BIT Capital GmbH raised its position in Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its holdings in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the period. Gilder Gagnon Howe & Co. LLC boosted its position in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares in the last quarter. Finally, Thrive Capital Management LLC grew its stake in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of NYSE:OSCR traded down $0.49 on Tuesday, hitting $19.94. The company had a trading volume of 26,587,606 shares, compared to its average volume of 5,574,048. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The company has a market cap of $5.08 billion, a PE ratio of 71.20 and a beta of 1.73. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The business has a 50 day moving average of $14.75 and a 200 day moving average of $14.51.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The firm's revenue for the quarter was up 42.2% compared to the same quarter last year. During the same period last year, the company earned $0.62 EPS. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company's stock, valued at $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 24.39% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

OSCR has been the subject of several recent analyst reports. Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday. Wall Street Zen downgraded shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Finally, Piper Sandler decreased their target price on Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research report on Monday, June 9th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $16.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.